YB-1: oncoprotein, prognostic marker and therapeutic target?

A Lasham, CG Print, AG Woolley, SE Dunn… - Biochemical …, 2013 - portlandpress.com
Hanahan and Weinberg have proposed the ‘hallmarks of cancer’ to cover the biological
changes required for the development and persistence of tumours [Hanahan and Weinberg (…

Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes

…, M Boehnke, F El Bouazzaoui, FS Collins, SH Dunn… - Diabetes, 2013 - Am Diabetes Assoc
Adiponectin is strongly inversely associated with insulin resistance and type 2 diabetes, but
its causal role remains controversial. We used a Mendelian randomization approach to test …

Undergraduate nursing students' perceptions of their clinical learning environment

SV Dunn, B Hansford - Journal of advanced nursing, 1997 - Wiley Online Library
The clinical learning environment (CLE) is an interactive network of forces influencing student
learning outcomes in the clinical setting. This study used mixed methods to identify factors …

Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram

J Triscott, M Rose Pambid, SE Dunn - Stem cells, 2015 - academic.oup.com
Cancer stem cells (CSCs) are thought to be at the root of cancer recurrence because they
resist conventional therapies and subsequently reinitiate tumor cell growth. Thus, targeting …

Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice

SE Dunn, FW Kari, J French, JR Leininger, G Travlos… - Cancer research, 1997 - AACR
Diet contributes to over one-third of cancer deaths in the Western world, yet the factors in the
diet that influence cancer are not elucidated. A reduction in caloric intake dramatically slows …

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival

…, J Carboni, M Gottardis, M Pollak, SE Dunn - Cancer research, 2008 - AACR
Drugs that target the insulin-like growth factor-I receptor (IGF-IR) and/or insulin receptor (IR)
are currently under investigation for a variety of malignancies including breast cancer. …

The development of a clinical learning environment scale

SV Dunn - Journal of advanced nursing, 1995 - Wiley Online Library
Within nursing, there is a strong demand for high‐quality, cost‐effective clinical education
experiences that facilitate student learning in the clinical setting The clinical learning …

Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells

…, C Blake-Gilks, M Chen, CJ Pallen, SE Dunn - Oncogene, 2005 - nature.com
Akt/PKB is a serine/threonine kinase that promotes tumor cell growth by phosphorylating
transcription factors and cell cycle proteins. There is particular interest in finding tumor-specific …

Divergent clonal selection dominates medulloblastoma at recurrence

…, J Sterba, K Zitterbart, S Puget, O Ayrault, SE Dunn… - Nature, 2016 - nature.com
The development of targeted anti-cancer therapies through the study of cancer genomes is
intended to increase survival rates and decrease treatment-related toxicity. We treated a …

A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer

SE Dunn, M Ehrlich, NJH Sharp, K Reiss, G Solomon… - Cancer research, 1998 - AACR
The 5-year survival rate for women with metastatic breast cancer is only 25–30%; thus, the
need to improve treatment is apparent. Overexpression of insulin-like growth factor-I receptor (…